Status:
COMPLETED
Association Between Trimethylamine-N-oxide and Gestational Diabetes Mellitus
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
20-45 years
Brief Summary
Background: The microbiota-dependent metabolite trimethylamine-N-oxide (TMAO) has been reported as a novel and independent risk factor for the development of cardiovascular and metabolic diseases, but...
Eligibility Criteria
Inclusion
- Age ≥ 20 years;
- Screened for GDM during 24-32 weeks of gestation;
- With fasting blood samples collected before 20 weeks of gestation (only for nested case-control subjects).
Exclusion
- History of a diagnosis of diabetes or gestational diabetes;
- History of receiving pharmacological treatment known to affect glucose metabolism;
- Clinically significant neurological, endocrinological or other systemic diseases and multiple pregnancies.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
1694 Patients enrolled
Trial Details
Trial ID
NCT03415295
Start Date
August 1 2012
End Date
June 30 2017
Last Update
January 31 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.